Pembrolizumab‐induced reactivation of bullous pemphigoid
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Dermatology"
DOI: 10.1111/ijd.15366
Abstract: Pembrolizumab-induced reactivation of bullous pemphigoid Dear Editor, Pembrolizumab is a programmed cell death protein 1 (PD1) inhibitor approved for use in several solid carcinomas. It reverses T-cell suppression, causing immune stimulation. Consequently, various immune-related adverse… read more here.
Keywords: dermatology; induced reactivation; bullous pemphigoid; reactivation ... See more keywords